Fiche personne
Coordonnées
Centre Georges-François Leclerc
1 rue du Professeur Marion
BP 77980
21079 DIJON
03 80 73 75 38
Territoire
Bourgogne
Statut
Interne
Affiliation
Équipes/plateformes
Projets
Evaluation of a Vaccine Associating NEo-antigens and adjuvant to SENsitize Tumors resistant to IMmunotherapy: a Proof of concept (EVANeSenT ImP)
2022 - Porteur du projet : Dr BELLIO Hélène
Publications
Cancer cell-derived IL-1β reverses chemo-immunotherapy resistance in non-small cell lung cancer.
Perrichet A, Lecuelle J, Limagne E, Thiefin M, Bellio H, Jacob P, Aucagne R, Aznague A, Russo P, Gaucher F, Roussot N, Yang X, Vernet T, Nuttin L, Ilie A, Rageot D, Derangère V, Huppe T, Zippelius A, Routy B, Truntzer C, Chalmin F, Ghiringhelli F, Rébé C
Nat Commun. 2025 11 21;16(1):10244
Metastatic osteosarcoma, patterns of care and outcomes of patients in a real-life national setting over a decade.
Reich M, Dinart D, Bellio H, Berchoud J, Jean-Denis M, Bonneau M, Winter S, Brunet M, Duong R, Nannini S, Gantzer J, Narciso B, Piperno-Neumann S, Valentin T, Marec-Berard P, Brahmi M, Bompas E, Anract P, Goldwasser F, Perret R, Le Cesne A, Gaspar N, Boudou-Rouquette P, Bellera C, Toulmonde M
Int J Cancer. 2025 09 28;:
FOLFIRINOX-3 plus bevacizumab (bFOLFIRINOX3) in chemo-refractory metastatic colorectal cancer: a multicenter phase II trial.
Bellio H, Roussot N, Bertaut A, Hervieu A, Zanetta S, Tharin Z, Vincent J, Bengrine L, Hennequin A, Guion JF, Boudrant A, Collot T, Ghiringhelli F, Fumet JD
Future Oncol. 2025 02 6;:1-8
